Firms, funds, people, portfolio companies and transactions from sworn filings and cited announcements, kept as a graph with a date and a source on every edge. Reported gross assets are never fund size, regulatory AUM is never dry powder, and a deal value prints only when someone disclosed it.

Transactions / DCL Medical Laboratories

TSCP Acquires DCL Medical Labs

Platform acquisitionannouncedannounced Oct 4, 2007Fact
What happened
Target
DCL Medical Laboratories
Platform
not an add-on on record
Control
Control
Share acquired
unknown
Industry
business_services / testing
Target location
unknown
Seller kind
unknown
Rollover
unknown
Values, only where disclosed
Enterprise value
Not disclosed
Purchase price
Not disclosed
Equity value
Not disclosed
Target revenue
Not disclosed
Target EBITDA
Not disclosed
Multiple
Not disclosed
Parties and roles
3 named
Buy side
  • Robert DunnDeal partnerconfirmed
    ““As a Midwest middle market firm, we look forward to growing our presence in St. Louis and Indianapolis,” says Robert Dunn, principal with Thompson Street.”
  • Thompson Street Capital Manager LLCSponsorconfirmed
    “Thompson Street Capital Partners announced the acquisition of DCL Medical Laboratories, Inc., headquartered in Indianapolis with operations in the St. Louis market. | published on Thompson Street Capital Manager's own news page www.tscp.com”
Side not stated
  • DCL Medical LaboratoriesTargetconfirmed
    “Thompson Street Capital Partners announced the acquisition of DCL Medical Laboratories, Inc., headquartered in Indianapolis with operations in the St. Louis market.”
Evidence
“Thompson Street Capital Partners announced the acquisition of DCL Medical Laboratories, Inc., headquartered in Indianapolis with operations in the St. Louis market.”
Press release wires (PR Newswire, GlobeNewswire, Business Wire public pages and RSS)confidence 80%recorded Sep 15, 2026
TSCP Acquires DCL Medical Labs | Private Equity Intelligence | DFX